Literature DB >> 26191356

Inhibitors of the Epidermal Growth Factor Receptor (EGFR) May Provide Effective Treatment for Lung Adenocarcinoma.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2015        PMID： 26191356      PMCID： PMC4499833          DOI： 10.1021/acsmedchemlett.5b00231

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.

Authors:  Mariam Jamal-Hanjani; James Spicer
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531

2.  The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations.

Authors:  Isamu Okamoto; Tetsuya Mitsudomi; Kazuhiko Nakagawa; Masahiro Fukuoka
Journal:  Ther Adv Med Oncol       Date:  2010-09       Impact factor: 8.168

3.  Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer.

Authors:  Manolo D'Arcangelo; Federico Cappuzzo
Journal:  Biologics       Date:  2013-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.